loading
Schlusskurs vom Vortag:
$86.97
Offen:
$86.7
24-Stunden-Volumen:
977.15K
Relative Volume:
0.93
Marktkapitalisierung:
$4.33B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.99M
KGV:
-28.71
EPS:
-2.9966
Netto-Cashflow:
$-24.94M
1W Leistung:
+2.91%
1M Leistung:
+7.55%
6M Leistung:
+77.62%
1J Leistung:
+87.61%
1-Tages-Spanne:
Value
$85.76
$88.01
1-Wochen-Bereich:
Value
$82.95
$88.86
52-Wochen-Spanne:
Value
$41.50
$90.32

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Name
Firmenname
Soleno Therapeutics Inc
Name
Telefon
650-213-8444
Name
Adresse
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Name
Mitarbeiter
92
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
SLNO's Discussions on Twitter

Vergleichen Sie SLNO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SLNO
Soleno Therapeutics Inc
86.02 4.41B 0 -38.99M -24.94M -2.9966
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-23 Eingeleitet TD Cowen Buy
2025-03-05 Fortgesetzt Stifel Buy
2024-12-02 Bestätigt Robert W. Baird Outperform
2024-12-02 Bestätigt Stifel Buy
2024-09-03 Eingeleitet H.C. Wainwright Buy
2024-05-10 Eingeleitet Robert W. Baird Outperform
2024-02-05 Eingeleitet Piper Sandler Overweight
2024-01-23 Eingeleitet Stifel Buy
2023-11-21 Fortgesetzt Guggenheim Buy
2020-09-29 Eingeleitet Guggenheim Buy
2020-01-10 Eingeleitet Craig Hallum Buy
2019-12-23 Eingeleitet Oppenheimer Outperform
2018-02-13 Bestätigt Maxim Group Buy
Alle ansehen

Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten

pulisher
Jul 22, 2025

Soleno Therapeutics Inc. Stock Analysis and ForecastFree Consultation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Soleno Therapeutics Inc. stockTremendous wealth creation - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is Soleno Therapeutics Inc. a good long term investmentConsistently high yield - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Soleno Therapeutics Inc. stock priceFast-track wealth growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Soleno Therapeutics’ Vykat XR Exceeds Sales Expectations - Yahoo Finance

Jul 21, 2025
pulisher
Jul 19, 2025

Soleno gains as Betaville cites buyout interest (update) - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

(SLNO) Trading Report - news.stocktradersdaily.com

Jul 18, 2025
pulisher
Jul 16, 2025

Soleno Therapeutics: A Strategic Capital Raise Balances M&A Optionality with Long-Term Growth Potential - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Soleno Therapeutics: Fairly Valued Despite M&A Expectations - Seeking Alpha

Jul 16, 2025
pulisher
Jul 15, 2025

Soleno Therapeutics (SLNO) Receives a Buy from Oppenheimer - The Globe and Mail

Jul 15, 2025
pulisher
Jul 14, 2025

Mintz Advises on Soleno Therapeutics’ $200 Million Public Offering - Mintz

Jul 14, 2025
pulisher
Jul 13, 2025

Soleno Therapeutics Shares Dip Following $200 Million Stock Offering Pricing - MSN

Jul 13, 2025
pulisher
Jul 12, 2025

Soleno Therapeutics stock dips on proposed $200M offering - MSN

Jul 12, 2025
pulisher
Jul 12, 2025

Baird Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Raises Target Price to $121 - 富途牛牛

Jul 12, 2025
pulisher
Jul 11, 2025

Stifel reiterates Buy rating on Soleno Therapeutics stock amid strong Vykat launch - Investing.com Nigeria

Jul 11, 2025
pulisher
Jul 11, 2025

Stifel reiterates Buy rating on Soleno Therapeutics stock amid strong Vykat launch By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Soleno Therapeutics Announces Public Stock Offering - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

In Brief: Soleno To Raise $200m To Boost Vykat XR Launch - insights.citeline.com

Jul 11, 2025
pulisher
Jul 11, 2025

Soleno Therapeutics stock soars as Stifel reiterates Buy on strong Vykat sales - Investing.com Australia

Jul 11, 2025
pulisher
Jul 11, 2025

Soleno Therapeutics prices $200M public offering - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

Baird raises Soleno Therapeutics stock price target to $121 on strong Vykat XR sales By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock - GlobeNewswire

Jul 11, 2025
pulisher
Jul 10, 2025

Baird raises Soleno Therapeutics stock price target to $121 on strong Vykat XR sales - Investing.com Nigeria

Jul 10, 2025
pulisher
Jul 10, 2025

Firm Advises Soleno Therapeutics on $200 Million Public Offering - Wilson Sonsini

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno reports preliminary Q2 revenue of $31-33 million for VYKAT XR - Investing.com Nigeria

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock - GlobeNewswire

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno sales of new Prader-Willi drug rise faster than expected - BioPharma Dive

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics Prices $200 Mln Public Offering To Support VYKAT XR Launch - Nasdaq

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics stock falls after pricing $200 million offering By Investing.com - Investing.com Canada

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics stock falls after pricing $200 million offering - Investing.com

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics prices public offering at $85 per share - Investing.com

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics prices public offering at $85 per share By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics Secures $200M Public Offering to Commercialize Breakthrough Prader-Willi Treatment - Stock Titan

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics stock soars as Stifel reiterates Buy on strong Vykat sales By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics: Q2 2025 Results Signal Breakout Potential in Rare Disease Market - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics announces preliminary financial and operational results for Q2 - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics' $200M Secondary Offering: Catalyst for Growth or Dilution Danger Zone? - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics Reports Q2 Preliminary Net Revenue - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics Proposes $200 Million Public Offering - MarketScreener

Jul 10, 2025

Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):